We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Heart Attack Risk Determined by Specific Genes

By HospiMedica International staff writers
Posted on 17 Feb 2009
The genetic risk of suffering a heart attack, regardless of a person's ethnic background, might be predicted by a simple blood test. More...


A group of Canadian and British investigators pinpointed specific genes and their association with an increased risk of heart attack. They extracted DNA from 8,795 individuals of European, south Asian, Arab, Iranian, and Nepalese origin and genotyped 1,536 single nucleotide polymorphisms (SNPs) from 103 genes. SNPs are single base pair variations in DNA, which occur within genes and, in some cases, change the production of proteins or alter the expression of other genes.

The results of the study showed a significant association between four genes, and high cholesterol levels, particularly ApolipoproteinB (ApoB)/A1 levels, which is the primary protein involved in "bad cholesterol" and responsible for carrying cholesterol to tissues. The scientists concluded that 13 common SNPs were associated with heart disease risk factors and one variant was independently associated with the risk of a heart attack.

"Most genetic studies have focused on studying white Caucasians," said Professor Sonia Anand, director of the Population Genomics Program at McMaster University (Hamilton, ON, Canada). "The unique contribution of our study is that we demonstrate that common genetic variants are indeed common across five ethnic groups. Furthermore, we are able to put the contribution of these factors on the risk of heart attack into perspective, demonstrating that the nine risk factors account for the vast majority of heart attacks and the genetic variants while important only add a small independent contribution to the risk of heart attack."

An earlier study led by Professor Salim Yusuf at McMaster University showed that nine risk factors accounted for more than 90% of the risk for heart attacks globally. Those nine risk factors are dyslipidemia/high cholesterol, diabetes, hypertension, abdominal obesity, tobacco, physical inactivity, psychosocial stressors, low fruit and vegetable intake, and no alcohol consumption. Together with the genetic variants (SNPs), the prediction of risk of myocardial infarction (MI) was increased by 1.6%.

Scientists believe that common SNPs may be associated with the development of a number of chronic diseases such as cancer, diabetes, vascular disease, and some forms of mental illness.

Related Links:

McMaster University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.